Evidence map›Paper›PMID 40583823›Full record

ArticleAngewandte Chemie (International ed. in English)2025

Bicyclic Selenenyl Sulfides with Tuned Bioreductive Step Rates Reveal Constraints for Probes Targeting Thioredoxin Reductase.

Lukas Zeisel, Lucas Dessen Weissenhorn, Karoline C Scholzen, Andrea Madabeni, Laura Orian, Elias S J Arnér, Oliver Thorn-Seshold

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lukas ZeiselFaculty of Chemistry and Food Chemistry, TU Dresden, Bergstrasse 66, 01069, Dresden, Germany.ORCID 0000-0001-7813-7099
Lucas Dessen WeissenhornDepartment of Pharmacy, LMU Munich, Butenandtstr. 5-13, 81377, Munich, Germany.
Karoline C ScholzenDivision of Biochemistry, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Solnavägen 9, 17165, Solna, Sweden.ORCID 0000-0002-5403-0411
Andrea MadabeniDepartment of Chemical Sciences, University of Padova, Via Marzolo 1, 35129, Padova, Italy.
Laura OrianDepartment of Chemical Sciences, University of Padova, Via Marzolo 1, 35129, Padova, Italy.ORCID 0000-0002-1673-5111
Elias S J ArnérDivision of Biochemistry, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Solnavägen 9, 17165, Solna, Sweden.ORCID 0000-0002-4807-6114
Oliver Thorn-SesholdFaculty of Chemistry and Food Chemistry, TU Dresden, Bergstrasse 66, 01069, Dresden, Germany.ORCID 0000-0003-3981-651X

Funding

German Federal Ministry of Education and Research 161B0632German Research Foundation 400324123Hungarian Ministry of Human Capacities ÁEEK/41872-16/2020Hungarian National Laboratories Excellence program (under the National Tumor Biology Laboratory project, NLP-17)Hungarian National Research, Development and Innovation Office ED_18-1-2019-0025Hungarian Thematic Excellence Programme TKP2020-NKA-26Karolinska Institutet, the Knut and Alice Wallenberg Foundations KAW 2015.0063Karolinska Institutet, the Knut and Alice Wallenberg Foundations KAW 2019.0059Munich Centre for NanoScience initiative (CeNS)Swedish Cancer Society 19 0330 PjSwedish Cancer Society CAN 2018/333Swedish Research Council 2017-01872Università degli Studi di Padova
6 · The paper itself

Abstract

The reductive activation of dichalcogenide probes by thiol-type oxidoreductases proceeds through a cascade of consecutive, partly reversible steps. Stereocontrol elements can modulate the reaction rates of these steps to reach substrate-controlled kinetic selectivity for reductase chemotypes in live cells. We now deploy regio-, diastereo-, template-, and pH-control elements to shape the reactivity of unprecedented bicyclic selenenyl sulfides (SeSP), arriving at probes that selectively target the mammalian selenoenzyme thioredoxin reductase TrxR1. We accessed these densely functionalised cis- or trans-fused 1,2-thiaselenanes on gram scale over 5 steps by using a regioselective key step that elaborates an unusual, differentially protected 2,2'-bis-aziridine intermediate through sequential one-pot chalcogen introduction and selenenyl sulfide formation. By profiling a set of regio- and diastereoisomeric bicycles for their partly or fully reversible reactivity during reductive activation, we show how effects that slow their reduction steps (addition then resolution) can compensate by vastly accelerating subsequent activation (cyclisation) speeds, such that cellular processing is effective and TrxR-selective. More broadly, this study shows how multistep cascade probes can leverage conformational effects and internal noncovalent interactions to differentiate step kinetics along their on-target versus off-target reaction pathways, thus achieving reaction-based target selectivity in complex biological settings.

Indexed as

Organoselenium CompoundsSulfidesThioredoxin-Disulfide ReductaseThioredoxin Reductase 1HumansKineticsMolecular StructureOxidation-ReductionStereoisomerismOrganoselenium CompoundsSulfidesThioredoxin-Disulfide ReductaseThioredoxin Reductase 1Chemical probesDisulfidesRedox biochemistrySelenenyl sulfidesSelenium

Identifiers

PMID40583823
PMCPMC12377444

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.